See All Slides - tctmd.com

Slides

Presentation TCT 2014

Regular Drug-Eluting Stent Versus Dedicated Bifurcation Sirolimus-Eluting BiOSS LIM® Stent In Coronary Bifurcation Treatment ? Randomized POLBOS II Study_

Presenter: Jacek Bil

September 16, 2014

Presentation TCT 2014

Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE

Presenter: Fausto Feres

September 16, 2014

Presentation TCT 2014

REASONS FOR HOSPITAL READMISSION WITHIN ONE YEAR AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION

Presenter: Stefan Stortecky

September 16, 2014

Presentation TCT 2014

Short-Duration Versus Guideline-Recommended 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation

Presenter: Giulio Stefanini

September 16, 2014

Presentation TCT 2014

Characterization of the Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High Risk Patients With Aortic Stenosis

Presenter: Ran Kornowski

September 16, 2014

Presentation TCT 2014

Renal Artery Denervation With A New Simultaneous Multielectrode Catheter For Treatment Of Resistant Hypertension: 12-Month Update From The SYMPLICITY Spyral First-In-Man Study

Presenter: Robert Whitbourn

September 16, 2014

Presentation TCT 2014

Comparable outcomes on single use of clopidogrel vs_ dual antiplatelet therapy after coronary stenting in patients with acute myocardial infarction

Presenter: Jun-Hyok Oh

September 16, 2014

Presentation TCT 2014

Femoral Approach with Systematic Use of FemoSeal? Closure Device Compared to Radial Approach in Primary Angioplasty: a Propensity-matched Comparison

Presenter: Stefano Rigattieri

September 16, 2014

Presentation TCT 2014

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Presenter: Bernard De Bruyne

September 16, 2014

Presentation TCT 2014

Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy

Presenter: Dietmar Trenk

September 16, 2014

Advertisement

Slides

Regular Drug-Eluting Stent Versus Dedicated Bifurcation Sirolimus-Eluting BiOSS LIM® Stent In Coronary Bifurcation Treatment ? Randomized POLBOS II Study_

Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE

REASONS FOR HOSPITAL READMISSION WITHIN ONE YEAR AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION

Short-Duration Versus Guideline-Recommended 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation

Characterization of the Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High Risk Patients With Aortic Stenosis

Renal Artery Denervation With A New Simultaneous Multielectrode Catheter For Treatment Of Resistant Hypertension: 12-Month Update From The SYMPLICITY Spyral First-In-Man Study

Comparable outcomes on single use of clopidogrel vs_ dual antiplatelet therapy after coronary stenting in patients with acute myocardial infarction

Femoral Approach with Systematic Use of FemoSeal? Closure Device Compared to Radial Approach in Primary Angioplasty: a Propensity-matched Comparison

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content